BICX (BioCorRx) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 08, 2026)


BICX BioCorRx Inc BICX
37 GF Score
Price $0.40
GF Value $2.76
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is BioCorRx Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

BioCorRx's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

BICX vs HLYK, AMS, BMGL: Margin of Safety % (DCF Dividends Based) Comparison

For the Medical Care Facilities subindustry, BioCorRx's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioCorRx Margin of Safety % (DCF Dividends Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BioCorRx's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where BioCorRx's Margin of Safety % (DCF Dividends Based) falls into.


BICX
37GF Score
BioCorRx Inc BICX
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BioCorRx (BICX) Overvalued in 2026?

Based on GuruFocus' analysis, BioCorRx stock appears to be undervalued. The current stock price of $0.40 is trading 85.5% below its estimated GF Value™ of $2.76. GuruFocus considers BioCorRx to be Possible Value Trap.

Key valuation signals for BICX:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: $2.76 vs. price of $0.40 (85.5% below fair value)
  • GF Score™: 37/100 with 7 warning signs

No single metric tells the full story. See the BICX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioCorRx Business Description

Address 2390 East Orangewood Avenue, Suite 570, Anaheim, CA, USA, 92806
BioCorRx Inc through its subsidiaries, develops and provides addiction treatment solutions, offering an approach to the treatment of substance use and other related disorders. The company makes the Beat Addiction Recovery Program and UnCraveRx Weight Loss Management Program available to healthcare providers to utilize when the healthcare provider determines it is medically appropriate and indicated for their patients. Its products include BICX102 and BICX104. It operates in a single segment.
37GF Score

Get the complete analysis for BICX

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price
$2.76
GF Value